Latest Genentech Stories
SUNNYVALE, Calif., Aug. 18, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that it has appointed Shawn Cline Tomasello as its Chief Commercial Officer. Ms.
Over Three-Quarters of Physicians View Ophthotech's Fovista as an Emerging Therapy with High Potential Value for Wet AMD, According to Findings from Decision Resources Group BURLINGTON, Mass.,
New PSA Inspires Everyone to Come Together in the Spirit of Collaboration and to Advance Cancer Research LOS ANGELES and NEW YORK, July 30, 2014 /PRNewswire-USNewswire/ -- Stand Up
Pharmica Consulting, the industry leader in life science processes and technology, is pleased to announce that Naseem Buckley of Genentech will speak at Pharmica’s SharePoint Conference for
While Expressing Concerns about Reimbursement, EU5 Payers Look Favorably on Identifying Anti-IL5 Therapy-Responsive Patients, According to Findings from Decision Resources Group BURLINGTON,
Former Genentech executive to lead Moderna's first venture company, focused exclusively in novel biology for oncology drug development CAMBRIDGE, Mass., July 1, 2014 /PRNewswire/ --
The Lung-MAP trial uses a multi-drug, targeted screening approach to match patients with promising new cancer treatments based on their unique tumor profiles BETHESDA, Md., June 16,
INCLINE VILLAGE, Nev., June 10, 2014 /PRNewswire/ -- PDL BioPharma, Inc.
Roche/Genentech's Avastin Continues to Garner the Greatest Physician-Reported Patient Share in DME Due to Its Low Relative Cost, According to Findings from Decision Resources Group BURLINGTON,
Ultimate Award Recipient Rackspace and Finalists including Cisco, ConAgra Foods, Genentech and Tata Consultancy Services focus on programs to acquire, grow and retain employees, manage change, and
- A volcanic mudflow.